Flow regulating implants

Information

  • Patent Grant
  • 7862531
  • Patent Number
    7,862,531
  • Date Filed
    Friday, June 25, 2004
    20 years ago
  • Date Issued
    Tuesday, January 4, 2011
    14 years ago
Abstract
A flow regulating implant is provided with one or more grooves for allowing fluid flow. One or more grooves may have a constant or varying cross-section along its length. One or more grooves may have in it biodegradable material, absorbable material, and/or threads or sutures. A resilient band or coating may be placed around the implant or one or more grooves, to act as a pressure regulator. The implant may have a side projection, such as a side pin, for engaging tissue. The implant may comprise two or more parts that are held at a distance from each other to allow fluid flow between the parts.
Description
FIELD OF THE INVENTION

The invention relates generally to flow regulating implants, for example ophthalmic implants for treatment of glaucoma.


BACKGROUND OF THE INVENTION

U.S. Pat. No. 5,868,697 discloses devices and methods for regulating fluid flow. The devices and methods are useful, for example, in the treatment of glaucoma, by providing for the flow of aqueous humor from the eye to reduce intraocular pressure (IOP). The devices and methods disclosed in that patent are expressly incorporated by reference into this specification.


As with the devices and methods disclosed in U.S. Pat. No. 5,868,697, the devices and methods disclosed herein are also for regulating fluid flow. The devices and methods disclosed herein are useful, for example, in the treatment of glaucoma, by providing for the flow of aqueous humor from the eye to reduce intraocular pressure (IOP).


SUMMARY OF THE INVENTION

In certain embodiments, the invention is directed to an improved flow regulating implant that has one or more grooves for allowing fluid flow.


In certain embodiments, one or more grooves may have a constant cross-section along its length.


In certain embodiments, one or more grooves may have a varying cross-section along its length. For example, one or more grooves may be tapered, as a funnel. The wider end may be at the inlet end or the outlet end.


In certain embodiments, one or more grooves may have in it biodegradable material, absorbable material, and/or threads or sutures.


In certain embodiments, a resilient band or coating may be placed around the implant or one or more grooves, to act as a pressure regulator.


In certain embodiments, in addition to one or more grooves, the implant may have a tube passage running through it. The tube passage may have in it biodegradable material, absorbable material, and/or threads or sutures.


In certain embodiments, the implant may have a side projection, such as a side pin, for engaging tissue. The side projection or pin may be useful for resisting rotation and/or firmly holding the implant within the tissue.


In certain embodiments, the implant may comprise two or more parts that are held at a distance from each other to allow fluid flow between the parts.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a first embodiment of a flow regulating implant;



FIG. 2 is an alternative perspective view of the flow regulating implant of FIG. 1;



FIG. 3 is an alternative perspective view of the flow regulating implant of FIG. 1;



FIG. 4 is a perspective view of the flow regulating implant of FIG. 1, with material in the side grooves;



FIG. 5 is a perspective view of the flow regulating implant of FIG. 1, with threads or sutures in the side grooves;



FIG. 6 is a perspective view of the flow regulating implant of FIG. 1, with a flow regulating band or coating around the implant;



FIG. 7 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves, with holes at the outlet ends of the grooves;



FIG. 8 is a perspective view of another alternative embodiment of a flow regulating implant with side grooves, with a hole in the flange at the outlet end of the implant;



FIG. 9 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves, with an alternative flange design at the outlet end of the implant;



FIG. 10 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves, with a tube passage running through the implant;



FIG. 11 is a perspective view of the flow regulating implant of FIG. 10, with a thread or suture in the tube passage;



FIG. 12 is a perspective view of an alternative embodiment of a flow regulating implant, with a side pin;



FIG. 13 is a perspective view of an alternative embodiment of a flow regulating implant, comprising two parts that are held at a distance from each other to allow fluid flow between the parts;



FIG. 14 is a perspective view of an alternative embodiment of a flow regulating implant, comprising two parts that are held at a distance from each other to allow fluid flow between the parts, wherein the two parts may be pushed together or moved apart.





DETAILED DESCRIPTION


FIGS. 1 to 3 illustrate a first embodiment of a flow regulating implant. The illustrated implant is in the form of an intraocular implant 10. The implant 10 comprises a shaft 11 and a flange (or plate or disk) 12. The cross-section of the shaft may take any suitable shape, for example square, rectangular, ellipsoidal, circular, or an irregular shape. In this illustrated embodiment, the plane of the flange 12 forms an angle with the shaft 11 that corresponds generally to the angle between the surface of the sclera of an eye and the intended axis of insertion of the implant 10. The flange 12 limits the depth of insertion and stabilizes the device. The angling of the flange 12 helps limit or prevent rotation of the device. In certain applications, it may be desired to remove the device, in which case the flange may be used for that purpose.


The implant 10 has an inlet end 13 and an outlet end 14. The flange 12 is connected to the shaft 11 at the outlet end 14 of the implant 10. The implant 10 may have one or more retention projections 15 for retaining the implant 10 after insertion. The retention projection(s) 15 may take any suitable form.


In the illustrated embodiment, the shaft 11 has a rounded tip at the inlet end 13 of the implant 10. It will be appreciated that the tip may take other suitable forms. For example, the tip may be a needle-like tip formed by a beveled surface, angled sharply for easy insertion into the eyeball.


The implant 10 has two side grooves 16A, 16B. In the illustrated embodiment, the side grooves 16A, 16B extend the full length of the implant 10, from the inlet end 13 to the outlet end 14. The side grooves 16A, 16B are in the side of the shaft 11 and extend through the flange 12.


An implant in accordance with the invention may be inserted by methods disclosed in U.S. Pat. No. 5,868,697, incorporated herein by reference. The insertion of the implant is not restricted to those methods. In certain instances, it may be desirable to implant the device such that the flange is located under scleral flap, i.e., a flap of tissue cut from the sclera. In such a method, a scleral flap is carefully cut from the sclera. The cut is preferably not made all the way through the sclera to the anterior chamber. Rather, the cut extends only part way through, to create the scleral flap that can be moved away to expose a place for insertion of the implant. With the scleral flap lifted, the implant is inserted in the intended implantation site, with the flange under the scleral flap. The implantation of the device under a scleral flap may assist in absorption of fluid. It also may assist in retention of the device.


With the device as illustrated in FIGS. 1 to 3, in operation, the grooves 16A, 16B form passageways for fluid to flow from the inlet end 13 toward the outlet end 14 of the implant 10. In the case of an intraocular implant, the aqueous humor in the eye can flow along the grooves from the inlet end 13 toward the outlet end 14.


The grooves 16A, 16B are directly adjacent the tissue into which the implant 10 is implanted. Thus, for example, the scleral tissue of the eye will surround the implant. In this manner, the scleral tissue can function as a valve to control the flow of fluid out of the eye. When the pressure in the anterior chamber is low, the tissue is close around the implant and in the grooves to block or limit the flow of fluid along the grooves. When the pressure in the anterior chamber is elevated, the fluid exerts pressure on the tissue to clear the passageway along the grooves, and fluid will flow along the grooves between the implant device and the tissue.


With the grooves, the aqueous humor flowing out of the anterior chamber is allowed to directly contact the scleral tissue, which allows for direct absorption of the aqueous humor by the sclera. The fluid may be absorbed by the sclera or may flow out, for example underneath the conjunctiva.


The groove(s) may take any suitable form. For example, one or more grooves may be shaped as a funnel, tapering from one end to the other. The wider end may be at the outlet end or the inlet end, depending on the desired application. Other modifications to the size, shape, and/or cross-sectional configuration of the groove(s) may be made.


It will be appreciated that in addition to the flow regulation characteristics, the grooves may serve the additional benefit of limiting or preventing rotation of the device. It will also be appreciated that non-circular cross-sections for the shaft will also help limit or prevent rotation of the device. For example, a cross-section having corners, like a square, rectangular or other polygonal cross-section, will help limit or prevent rotation. In addition, a cross-section with different dimensions in different direction, like an elliptical or rectangular cross-section, will help limit or prevent rotation. The grooves may help to limit or prevent rotation even with an otherwise circular cross-section for the shaft. The tissue in the gutters may help hold the position of the device.



FIG. 4 illustrates the flow regulating implant of FIG. 1, with material 17 in the side grooves. In this example, the material 17 may be a biodegradable material, an absorbable material, or a material that may be ablated with a laser. Such materials may act to block or limit flow initially and to allow more flow over time. For example, a physician may ablate the laser-ablatable material at some period of time after implantation, or in increments over time. The biodegradable or absorbable material may act to block flow upon initial implantation and to erode or degrade over time to allow more flow. Further descriptions of the use of such materials in flow regulating implants are provided in U.S. Pat. Nos. 6,203,513 and 6,558,342, the disclosures of which are incorporated herein by reference.



FIG. 5 illustrates the flow regulating implant of FIG. 1, with threads or sutures 18 in the side grooves. The threads or sutures 18 may act to block or limit flow initially and to allow more flow over time. For example, a physician may remove the threads or sutures 18 at some period of time after implantation, or may remove one at a time in increments over time. It will be appreciated that more than one thread or suture 18 may be placed in each groove. Further descriptions of the use of threads or sutures in flow regulating implants are provided in U.S. Pat. No. 6,558,342, the disclosure of which is incorporated herein by reference.



FIG. 6 illustrates the flow regulating implant of FIG. 1, with a flow regulating band or coating 19 around the implant. The band or coating 19 may extend over only part of the length of the implant, as illustrated, or, alternatively, it may extend over the full length of the implant. The band or coating 19 may be shaped to extend into the grooves. The band or coating 19 is resilient and acts as valve to control the flow of fluid out of the eye. When the pressure in the anterior chamber is low, the band or coating 19 is close around the implant and in the grooves to block or limit the flow of fluid along the grooves. When the pressure in the anterior chamber is elevated, the fluid exerts pressure on the band or coating 19 to clear the passageway along the grooves, and fluid will flow along the grooves between the implant shaft and the band or coating 19.



FIG. 7 illustrates another embodiment of a flow regulating implant. This flow regulating implant 20 is similar to the flow regulating implant 10. The flow regulating implant 20 has a shaft 21, a flange 22, and grooves 26A, 26B (groove 26B not shown). In this embodiment, the flange has holes 27A, 27B in it at the outlet ends of the grooves 26A, 26B, respectively. These holes allow the flow of fluid away from the implant.



FIG. 8 illustrates another embodiment of a flow regulating implant. This flow regulating implant 30 is similar to the flow regulating implants described above. The flow regulating implant 30 has a shaft 31, a flange 32, and grooves 36A, 36B. In this embodiment, the flange has a hole 38 in it. With this hole, a suture may be used to attach the implant to tissue to fix it in place.



FIG. 9 illustrates a flow regulating implant 40. This flow regulating implant 40 is similar to the flow regulating implants described above. The flow regulating implant 40 has a shaft 41, a flange 42, and grooves 46A, 46B. In this embodiment, the flange 42 has a different shape, which may be useful in certain applications.



FIG. 10 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves. The implant 50 has tube passage 51 running through the implant. This tube passage 51 provides an additional passageway for fluid flow. The tube passage may have in it absorbable, biodegradable, laser-ablatable and/or removable material for blocking or partially obstructing fluid flow, and for allowing further flow over time. FIG. 11 illustrates the flow regulating implant of FIG. 10, with a thread or suture 58 in the tube passage 51.



FIG. 12 is a perspective view of an alternative embodiment of a flow regulating implant 60, with a side projection in the form of a side pin 68. Upon implantation, the pin 68 is fixed in the scleral tissue and serves to resist rotation of the device. The pin 68 may also assist in holding the device in the sclera, providing a sealing of the sclera around the shaft of the implant to prevent undesired leakage. The pin also fixes the device to prevent the possibility of the device pressing on and eroding the conjunctiva.


The projection or pin could be may of any suitable material, and it could be removable or changeable. For example, the projection or pin could be made of absorbable, biodegradable, laser-ablatable and/or removable material. The projection or pin 68 could be movable with a hole in the shaft 61, so that its length of projection from the shaft 61 could be adjustable. Also, a slot or other holes could be provided to allow adjustment of the positioning of the projection or pin.



FIG. 13 is a perspective view of an alternative embodiment of a flow regulating implant. The implant 70 comprises two parts 71, 72 that are held at a distance from each other to allow fluid flow between the parts. In implant 70, the two parts 71, 72 are joined to each other by two cylinders 73A, 73B. The implant may be formed as one piece, or the parts may be joined by any suitable means, for example welding. The two parts 71, 72 may be joined by just one cylinder or by parts of other shapes, for example, one or more spheres. Alternatively, the two parts may be shaped to be joined directly together with a space between them. It will be appreciated that the space 74 between the parts 71, 72 provides a space for the flow of fluid and allows further fluid contact with the sclera.



FIG. 14 illustrates a flow regulating implant 80 comprising an elongated portion having two elongated parts 81, 82 that are formed together as parts of a single, one-piece device. As illustrated in FIG. 14 and similar to previous embodiments discussed above, a flange 85 is attached to and projects at an angle with respect to each of the two elongated parts 81, 82. It will be appreciated that the space 84 between the parts 81, 82 provides a space for the flow of fluid and allows further fluid contact with the sclera, similar to the implant 70. The two parts 81, 82 may be pushed together or moved apart, which can control the spacing and thus the fluid flow.


An implant constructed in accordance with the invention may be manufactured entirely from or covered with any suitable material, such as stainless steel, silicon, gold, nitinol, Teflon, tantalum, PMMA, or any other suitable metallic or polymeric or other material. The entire device may be made from a degradable material. The device may be made by molding or any other suitable method of manufacture. The device may be manufactured as one piece or as separate pieces that are joined together. The implant may be coated with heparin or any other suitable coating.


Implants in accordance with the invention may be provided with other features and/or implanted with delivery devices and/or by other methods, for example those disclosed in U.S. Pat. Nos. 5,868,697; 6,203,513 and 6,558,342, discussed above.


As will be appreciated by persons having ordinary skill in the art, the various embodiments of implants described hereinabove are given by way of example only. Various changes, modifications and variations may be applied to the described embodiments without departing from the scope of the invention, defined by the appended claims.

Claims
  • 1. An implant for regulating fluid flow, the implant comprising: (a) an elongated portion comprising an insertion tip, an inlet and an outlet, a first elongated part and a second elongated part; wherein said insertion tip has a proximal end and a distal end, said proximal end of said insertion tip joining said first and second elongated parts, said first and second elongated parts disposed such that a greatest dimension thereof is a length thereof measured along an axial direction, and wherein a space extends along said elongated portion substantially in said axial direction between said first and second elongated parts, said space comprising said inlet disposed at said proximal end of said insertion tip and extending along said elongated portion substantially in said axial direction such that said space forms a flowpath from said inlet to said outlet; wherein said elongated portion further comprises a first lateral side and a second lateral side, such that said space forms a channel from said first lateral side of said elongated portion to said second lateral side of said elongated portion; and(b) a flange attached to at least the first elongated part, the flange being located at the outlet of the elongated portion.
  • 2. The implant of claim 1, wherein the flange projects from the first elongated part at an angle with respect to the first elongated part.
  • 3. The implant of claim 1, wherein the first elongated part and the second elongated part are formed together as parts of a single, one-piece implant.
  • 4. The implant of claim 1, wherein a distance between the first elongated part and the second elongated part is adjustable such that the first elongated part and second elongated part may be pushed together to a first position in which they are separated by a first distance and moved apart to a second position in which they are separated by a second distance greater than the first distance.
  • 5. The implant of claim 4, wherein the flange projects from the first elongated part at an angle with respect to the first elongated part.
  • 6. The implant of claim 4, wherein the first elongated part and the second elongated part are formed together as parts of a single, one-piece implant.
  • 7. The implant of claim 1, wherein the first part and second part are joined to each other by an additional piece.
US Referenced Citations (160)
Number Name Date Kind
15192 Peale Jun 1856 A
274447 Kennish Mar 1883 A
733152 Chisholm Jul 1903 A
1388172 Craddock Aug 1921 A
2431587 Schnee Nov 1947 A
2555076 Crossley May 1951 A
2867213 Thomas, Jr. Jun 1957 A
3159161 Ness Dec 1964 A
3272204 Artandi et al. Sep 1966 A
3310051 Schulte Mar 1967 A
3333588 Schulte Aug 1967 A
3421509 Fiore Jan 1969 A
3530860 Majoros Sep 1970 A
3589401 Harding Jun 1971 A
3788327 Donowitz et al. Jan 1974 A
3884238 O'Malley et al. May 1975 A
3890976 Bazell et al. Jun 1975 A
3913584 Walchle et al. Oct 1975 A
3915172 Wichterle et al. Oct 1975 A
3938529 Gibbons Feb 1976 A
3957035 Chassaing May 1976 A
3976077 Kerfoot, Jr. Aug 1976 A
4037604 Newkirk Jul 1977 A
4142526 Zaffaroni et al. Mar 1979 A
4153058 Nehme May 1979 A
4175563 Arenberg et al. Nov 1979 A
4290426 Luschen et al. Sep 1981 A
4299227 Lincoff Nov 1981 A
4303063 Stahl Dec 1981 A
4402681 Haas et al. Sep 1983 A
4457757 Molteno Jul 1984 A
4474569 Newkirk Oct 1984 A
4521210 Wong Jun 1985 A
4526343 d'Agostino et al. Jul 1985 A
4538611 Kelman Sep 1985 A
4554918 White Nov 1985 A
4563779 Kelman Jan 1986 A
4578058 Grandon Mar 1986 A
4587954 Haber May 1986 A
4598705 Lichtenberger Jul 1986 A
4604087 Joseph Aug 1986 A
4634418 Binder Jan 1987 A
4645493 Ferrando et al. Feb 1987 A
4660546 Herrick et al. Apr 1987 A
4692142 Dignam et al. Sep 1987 A
4722724 Schocket Feb 1988 A
4750901 Molteno Jun 1988 A
4750971 Maas et al. Jun 1988 A
4751926 Sasaki Jun 1988 A
4781675 White Nov 1988 A
4787885 Binder Nov 1988 A
4808183 Panje Feb 1989 A
4813941 Shea Mar 1989 A
4826478 Schocket May 1989 A
4863457 Lee Sep 1989 A
4886488 White Dec 1989 A
4909783 Morrison Mar 1990 A
4915684 MacKeen et al. Apr 1990 A
4934363 Smith et al. Jun 1990 A
4936825 Ungerleider Jun 1990 A
4942875 Hlavacek et al. Jul 1990 A
4946436 Smith Aug 1990 A
4959048 Seder et al. Sep 1990 A
4964850 Bouton et al. Oct 1990 A
4968296 Ritch et al. Nov 1990 A
5000731 Wong Mar 1991 A
5041081 Odrich Aug 1991 A
5053040 Goldsmith, III Oct 1991 A
5064417 Andreussi Nov 1991 A
5071408 Ahmed Dec 1991 A
5073163 Lippman Dec 1991 A
5092837 Ritch et al. Mar 1992 A
5098393 Amplatz et al. Mar 1992 A
5098438 Siepser Mar 1992 A
5106367 Ureche et al. Apr 1992 A
5127901 Odrich Jul 1992 A
5139502 Berg et al. Aug 1992 A
5147370 McNamara et al. Sep 1992 A
5167620 Ureche et al. Dec 1992 A
5171213 Price, Jr. Dec 1992 A
5171270 Herrick Dec 1992 A
5178604 Baerveldt et al. Jan 1993 A
5190552 Kelman Mar 1993 A
5207660 Lincoff May 1993 A
5217486 Rice et al. Jun 1993 A
5221278 Linkwitz et al. Jun 1993 A
5242449 Zaleski Sep 1993 A
5283063 Freeman Feb 1994 A
5300020 L'Esperance, Jr. Apr 1994 A
5318558 Linkwitz et al. Jun 1994 A
5322504 Doherty et al. Jun 1994 A
5326345 Price, Jr. Jul 1994 A
5338291 Speckman et al. Aug 1994 A
5342370 Simon et al. Aug 1994 A
5346464 Camras Sep 1994 A
5355871 Hurley et al. Oct 1994 A
5358492 Feibus Oct 1994 A
5360398 Grieshaber et al. Nov 1994 A
5360399 Stegmann Nov 1994 A
5370607 Memmen Dec 1994 A
5372577 Ungerleider Dec 1994 A
5380290 Makower et al. Jan 1995 A
D356867 Krupin Mar 1995 S
5397300 Baerveldt et al. Mar 1995 A
5403323 Smith Apr 1995 A
RE34998 Langerman Jul 1995 E
5433701 Rubinstein Jul 1995 A
5433714 Bloomberg Jul 1995 A
5451229 Geuder et al. Sep 1995 A
5454796 Krupin Oct 1995 A
5476445 Baerveldt et al. Dec 1995 A
5494484 Feingold Feb 1996 A
5520631 Nordquist et al. May 1996 A
5522845 Wenstrom, Jr. Jun 1996 A
5558629 Baerveldt et al. Sep 1996 A
5558630 Fisher Sep 1996 A
5601094 Reiss Feb 1997 A
5616118 Ahmed Apr 1997 A
5626558 Suson May 1997 A
5626559 Solomon May 1997 A
5660205 Epstein Aug 1997 A
5674286 D'Alessio et al. Oct 1997 A
5702414 Richter et al. Dec 1997 A
5704907 Nordquist et al. Jan 1998 A
5709698 Adams et al. Jan 1998 A
5713844 Peyman Feb 1998 A
5720760 Becker et al. Feb 1998 A
5741292 Mendius Apr 1998 A
5800376 Watson et al. Sep 1998 A
5807240 Muller et al. Sep 1998 A
5865831 Cozean et al. Feb 1999 A
5868697 Richter et al. Feb 1999 A
5879319 Pynson et al. Mar 1999 A
5893837 Eagles et al. Apr 1999 A
5968058 Richter et al. Oct 1999 A
6004302 Brierley Dec 1999 A
6007510 Nigam Dec 1999 A
6007511 Prywes Dec 1999 A
6050970 Baerveldt Apr 2000 A
6102045 Nordquist et al. Aug 2000 A
6168575 Soltanpour Jan 2001 B1
6186974 Allan et al. Feb 2001 B1
6203513 Yaron et al. Mar 2001 B1
6221078 Bylsma Apr 2001 B1
6245077 East et al. Jun 2001 B1
6264625 Rubenstein et al. Jul 2001 B1
6280468 Schachar Aug 2001 B1
6299640 Schachar Oct 2001 B1
6450984 Lynch et al. Sep 2002 B1
6730056 Ghaem et al. May 2004 B1
7008396 Straub Mar 2006 B1
7041077 Shields May 2006 B2
7207965 Simon Apr 2007 B2
20010000527 Yaron et al. Apr 2001 A1
20040015140 Shields Jan 2004 A1
20040088048 Richter et al. May 2004 A1
20040147870 Burns et al. Jul 2004 A1
20050119601 Lynch et al. Jun 2005 A9
20050266047 Tu et al. Dec 2005 A1
20060069340 Simon Mar 2006 A1
Foreign Referenced Citations (30)
Number Date Country
102747 Mar 1984 EP
228185 Jul 1987 EP
606188 Jul 1994 EP
1 310 222 May 2008 EP
2 721 499 Dec 1995 FR
2 757 068 Jun 1998 FR
63-305860 Dec 1988 JP
3-292953 Dec 1991 JP
5-115502 May 1993 JP
5-502811 May 1993 JP
8-155540 Jun 1996 JP
1191227 Nov 1985 SU
1797884 Feb 1993 SU
WO9108784 Jun 1991 WO
WO9200112 Jan 1992 WO
WO9320783 Oct 1993 WO
WO9402081 Feb 1994 WO
WO9409837 May 1994 WO
WO9413234 Jun 1994 WO
WO9417755 Aug 1994 WO
WO9421443 Sep 1994 WO
WO9535078 Dec 1995 WO
WO9603944 Feb 1996 WO
WO9620742 Jul 1996 WO
WO9636377 Nov 1996 WO
WO9830181 Jan 1998 WO
WO9926567 Jun 1999 WO
WO00 72788 Dec 2000 WO
2007087061 Aug 2007 WO
2008005873 Jan 2008 WO
Related Publications (1)
Number Date Country
20050288617 A1 Dec 2005 US